Rakovina Therapeutics, Inc. (VCO.P) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

MedBright AI Investments, Inc.

NeuPath Health, Inc.

Cliffside Capital Ltd.

BEACN Wizardry & Magic, Inc.

RE Royalties Ltd.

Edge Total Intelligence, Inc.

Cypherpunk Holdings, Inc.

Fredonia Mining, Inc.

Hispania Resources, Inc.

Tier One Capital LP

Rakovina Therapeutics, Inc.

Why is Rakovina Therapeutics, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Rakovina Therapeutics, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Rakovina Therapeutics, Inc.

-100.0%

0.01

986.48%

S&P/TSX 60

21.87%

1.42

15.38%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

-226.17%

EBIT to Interest (avg)

-2.29

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.97

EV to EBIT

-0.46

EV to EBITDA

-0.49

EV to Capital Employed

0.98

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

-213.34%

ROE (Latest)

-425.12%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

Mildly Bullish

No Trend

OBV

Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company

NET PROFIT(HY)

Higher at CAD -4.7 MM

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

EPS(Q)

Highest at CAD -0.08

-27What is not working for the Company

INTEREST(HY)

At CAD 0.23 MM has Grown at 72.45%

OPERATING CASH FLOW(Y)

Lowest at CAD -7.22 MM

PRE-TAX PROFIT(Q)

At CAD -1.78 MM has Fallen at -76.21%

NET PROFIT(Q)

At CAD -1.78 MM has Fallen at -76.21%

ROCE(HY)

Lowest at -332.03%

DEBT-EQUITY RATIO (HY)

Highest at 90.39 %

Here's what is working for Rakovina Therapeutics, Inc.

EPS

Highest at CAD -0.08

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CAD)

Raw Material Cost

Fallen by 0% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Rakovina Therapeutics, Inc.

Interest

At CAD 0.23 MM has Grown at 72.45%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CAD MM)

Pre-Tax Profit

At CAD -1.78 MM has Fallen at -76.21%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CAD MM)

Net Profit

At CAD -1.78 MM has Fallen at -76.21%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CAD MM)

Operating Cash Flow

Lowest at CAD -7.22 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CAD MM)

Debt-Equity Ratio

Highest at 90.39 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio